Stemmatters originated as a spin-off from University of Minho (3B’s Research Group).
Since its creation, Stemmatters strives to create meaningful value from applied biomedical research. Our ambition is to pursue patient benefit by developing novel medical technology that provides more safe and effective regenerative medicine.
Since its creation, Stemmatters strives to create meaningful value from applied biomedical research. Our ambition is to pursue patient benefit by developing novel medical technology that provides more safe and effective regenerative medicine.